Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:21 PM
Ignite Modification Date:
2025-12-24 @ 9:21 PM
NCT ID:
NCT03593304
Eligibility Criteria:
Inclusion Criteria:
* All patients, 18 years of age or older with newly diagnosed ALL going to start induction chemotherapy with Vincristine
* Patients ECOG Performance Status 0 to 3
* Patients with no preexisting autonomic neuropathy
* Patients with normal renal function (Serum creatinine \<1.5 mg/dl)
* No history of diabetes mellitus
* Patients agree to participate in the study signing an informed written consent
Exclusion Criteria:
* Pregnant women and nursing mothers
* Patients with clinical neuropathy due to diabetes mellitus and other causes like multiple sclerosis, spinal cord injury, post stroke
* Patients with head neck tumors
* Patients taking anticonvulsants, antidepressants, opioids, vitamin E and other neuropathic pain medication agents like topical anesthetic agents, non steroidal anti-inflammatory drugs (NSAIDs)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03593304
Study Brief:
Protocol Section:
NCT03593304